STOCK TITAN

AWM Investment Co. Reports 6.9% Holding in AYTU

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

AWM Investment Company, Inc. reports beneficial ownership of 619,874 shares of AYTU BioPharma common stock, equal to 6.9% of the class. These shares are held by Special Situations Private Equity Fund, L.P. (SSPE), for which AWM serves as investment adviser and over which AWM states it has sole voting and sole dispositive power.

The filing identifies David M. Greenhouse and Adam C. Stettner as controlling principals of AWM and members of MG Advisers, L.L.C., the general partner of SSPE. The filer certifies the securities were acquired in the ordinary course of business and are not held to change or influence control of the issuer.

Positive

  • Material minority stake: Ownership of 619,874 shares representing 6.9% of AYTU common stock is disclosed.
  • Sole voting and dispositive power: AWM states it holds exclusive authority to vote and dispose of the shares held by SSPE.
  • Passive intent certified: The filer certifies the shares were acquired in the ordinary course and are not held to change or influence control.

Negative

  • None.

Insights

TL;DR AWM holds a meaningful minority stake (6.9%) with sole voting/dispositive power through its advisory role.

The 6.9% position is material for a single institutional holder but remains below levels that typically trigger formal takeover dynamics. Because AWM reports sole voting and dispositive power over the 619,874 shares held by SSPE, the firm can determine voting and disposition decisions for that block. The filing's certification that the stake is held in the ordinary course and not to influence control reduces immediate governance risk, but the position size merits monitoring for future filings or changes in intent.

TL;DR The disclosure signals a concentrated, actionable holding but asserts a passive intent.

From a governance perspective, a 6.9% ownership by an adviser-controlled fund is notable: AWM can direct votes for the shares it advises. The filing explicitly states the shares were not acquired to change or influence control, consistent with a Schedule 13G filing posture. Investors should note the linkage between AWM, SSPE, and MG Advisers, which clarifies decision-making authority for the reported stake.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Private Equity Fund, L.P. (SSPE). (SSPE will hereafter be referred to as the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 619,874 shares of Common Stock of the Issuer (the Shares) held by SSPE


SCHEDULE 13G



AWM Investment Company, Inc.
Signature:Adam Stettner
Name/Title:Executive Vice President
Date:08/14/2025

FAQ

How many AYTU (AYTU) shares does AWM Investment Company hold?

619,874 shares, representing 6.9% of AYTU's common stock according to the filing.

Who holds the AYTU shares on behalf of AWM?

The shares are held by Special Situations Private Equity Fund, L.P. (SSPE), for which AWM is the investment adviser.

Does AWM have voting or dispositive power over the AYTU shares?

Yes. AWM reports sole voting power and sole dispositive power over the 619,874 shares held by SSPE.

Was the stake acquired to influence control of AYTU?

Per the filing's certification, the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.

Who are the named principals related to this filing?

The filing identifies David M. Greenhouse and Adam C. Stettner as members of MG Advisers and controlling principals of AWM.
Aytu Biopharma Inc

NASDAQ:AYTU

View AYTU Stock Overview

AYTU Rankings

AYTU Latest News

AYTU Latest SEC Filings

AYTU Stock Data

29.14M
9.77M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
DENVER